medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2015, Number 5

<< Back Next >>

Ann Hepatol 2015; 14 (5)

Transient hyperglycemia during liver transplantation does not affect the early graft function

Blasi A, Beltran J, Martin N, Martinez-Pallí G, Lozano JJ, Balust J, Torrents A, Taura P

Language: English
References: 27
Page: 675-687
PDF size: 151.54 Kb.


ABSTRACT

Background and rationale for the study. Hyperglycemia after graft reperfusion is a consistent finding in liver transplantation (LT) that remains poorly studied. We aim to describe its appearance in LT recipients of different types of grafts and its relation to the graft function. Material & methods. 436 LT recipients of donors after brain death (DBD), donors after cardiac death (DCD), and familial amyloidotic polyneuropathy (FAP) donors were reviewed. Serum glucose was measured at baseline, during the anhepatic phase, after graft reperfusion, and at the end of surgery. Early graft dysfunction (EAD) was assessed by Olthoff criteria. Caspase-3, IFN-γ, IL1β, and IL6 gene expression were measured in liver biopsy. Results. The highest increase in glucose levels after reperfusion was observed in FAP LT recipients and the lowest in DCD LT recipients. Glucose level during the anhepatic phase was the only modifiable predictive variable of hyperglycemia after reperfusion. No relation was found between hyperglycemia after reperfusion and EAD. However, recipients with the highest glucose levels after reperfusion tended to achieve the best glucose control at the end of surgery and those who were unable to control the glucose value after reperfusion showed EAD more frequently. The highest levels of caspase-3 were found in recipients with the lowest glucose values after reperfusion. In conclusion, glucose levels increased after graft reperfusion to a different extent according to the donor type. Contrary to general belief, transient hyperglycemia after reperfusion does not appear to impact negatively on the liver graft function and could even be suggested as a marker of graft quality.


REFERENCES

  1. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-67.

  2. van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31: 359-66.

  3. Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, Bouillon R, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006; 55: 3151-9.

  4. Wallia A, Parikh ND, Molitch ME, Mahler E, Tian L, Huang JJ, Levitsky J. Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection. Transplantation 2010; 89: 222-6.

  5. Ammori JB, Sigakis M, Englesbe MJ, O’Reilly M, Pelletier SJ. Effect of intraoperative hyperglycemia during liver transplantation. J Surg Res 2007; 140: 227-33.

  6. Harding SA, Mallett SV, Peachey TD, Cox DJ. Use of heparinase modified thrombelastography in liver transplantation. Br J Anaesth 1997; 78: 175-9.

  7. Di Filippo C, Cuzzocrea S, Rossi F, Marfella R, D’Amico M. Oxidative stress as the leading cause of acute myocardial infarction in diabetics. Cardiovasc Drug Rev 2006; 24: 77-87.

  8. Kamada H, Yu F, Nito C, Chan PH. Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction. Stroke 2007; 38: 1044-9.

  9. Bémeur C, Ste-Marie L, Montgomery J. Increased oxidative stress during hyperglycemic cerebral ischemia. Neurochem Int 2007; 50: 890-904.

  10. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, Greenstein SM, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-90.

  11. Maerz LL, Akhtar S. Perioperative glycemic management in 2011: paradigm shifts. Curr Opin Crit Care 2011; 17: 370-5.

  12. Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair JH, Fisher RA, Freise CE, et al. Outcomes of 385 adult-toadult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg 2005; 242: 314–23.

  13. Gillispie A, Rooyackers O, Wernerman J, Nowak G. Effect of extended cold ischemia time on glucose metabolism in liver grafts: experimental study in pigs. J Hepatobiliary Pancreat Surg 2007; 14: 183-8.

  14. de Bruijne JJ, de Koster P. Glycogenolysis in the fasting dog. Comp Biochem Physiol B 1983; 75: 553-5.

  15. Maeda H, Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Hanazaki K. Hyperglycemia during hepatic resection: continuous monitoring of blood glucose concentration. Am J Surg 2010; 199: 8-13.

  16. Broomhead R, Patel S, Fernando B, O’Beirne J, Mallett S. Resource implications of expanding the use of DCD organs in liver transplantation. Liver Transpl 2012; 18: 771-8.

  17. Bispo M, Marcelino P, Marques HP, Martins A, Perdigoto R, Aguiar MJ, Mourao L, et al. Domino versus deceased donor liver transplantation: association with early graft function and perioperative bleeding. Liver Transpl 2011; 17: 270-8.

  18. Cywes R, Greig PD, Sanabria JR, Clavien PA, Levy GA, Harvey PR, Strasberg SM. Effect of intraportal glucose infusion on hepatic glycogen content and degradation, and outcome of liver transplantation. Ann Surg 1992; 216: 235-7.

  19. Morgan GR, Sanabria JR, Clavien PA, Phillips MJ, Edwards C, Harvey PR, Strasberg S. Correlation of donor nutritional status with sinusoidal lining cell viability and liver function in the rat. Transplantation 1991; 51: 1176-83.

  20. Podrazik RM, Natale JE, Zelenock GB, D’Alecy LG. Hyperglycemia exacerbates and insulin fails to protect in acute renal ischemia in the rat. J Surg Res 1989; 46: 572-8.

  21. Behrends M, Martinez-Palli G, Niemann CU, Cohen S, Ramachandran R, Hirose R. Acute hyperglycemia worsens hepatic ischemia/reperfusion injury in rats. J Gastrointest Surg 2010; 14: 528-35.

  22. Hirose R, Xu F, Dang K, Liu T, Behrends M, Brakeman PR, Wiener-Kronish J, et al. Transient hyperglycemia affects the extent of ischemia-reperfusion-induced renal injury in rats. Anesthesiology 2008; 108: 402-14.

  23. Elias-Miró M, Jiménez-Castro MB, Rodés J, Peralta C. Current knowledge on oxidative stress in hepatic ischemia/ reperfusion. Free Radic Res 2013; 47: 555-68.

  24. Mallett SV, Kang Y, Freeman JA, Aggarwal S, Gasior T, Fortunato FL. Prognostic significance of reperfusion hyperglycemia during liver transplantation. Anesth Analg 1989; 68: 182-5.

  25. Egi M, Finfer S, Bellomo R. Glycemic control in the ICU. Chest 2011; 140: 212-220.

  26. Okada T, Kawahito S, Mita N, Matsuhisa M, Kitahata H, Shimada M, Oshita S. Usefulness of continuous blood glucose monitoring and control for patients undergoing liver transplantation. J Med Invest 2013; 60: 205-12.

  27. Haga S, Remington SJ, Morita N, Terui K, OzakiM. Hepatic ischemia induced immediate oxidative stress after reperfusion and determined the severity of the reperfusion-induced damage. Antioxid Redox Signal 2009; 11: 2563-72.




2020     |     www.medigraphic.com